☆Squadron Capital Management LLC
Quality Q
0.134
AUM ($M)
292
Positions
34
Turnover
0.38
Top-10 wt
73%
Herfindahl
0.078
History (qtrs)
3
Excess Return
+45.2%
AI Eval Run AI Eval
Holdings · 47 positions · portfolio value $292M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆RLMD funds › | RELMADA THERAPEUTICS INC | TRIM | — | 17.4% | -6.2% | 50.9 | 7,350,000 | -1,124,571 | 2 | — |
| ☆CCCC funds › | C4 THERAPEUTICS INC | ADD | Common Stock | 11.5% | +9.1% | 33.6 | 7,200,000 | +4,950,000 | 2 | +429.2% |
| ☆COGT funds › | COGENT BIOSCIENCES INC | ADD | Common Stock | 11.5% | -0.7% | 33.5 | 865,000 | +77,508 | 2 | — |
| ☆KOD funds › | KODIAK SCIENCES INC | ADD | Common Stock | 6.7% | +0.9% | 19.5 | 500,000 | +120,000 | 2 | — |
| ☆RLAY funds › | RELAY THERAPEUTICS INC | ADD | — | 6.2% | +3.5% | 18.1 | 970,000 | +297,500 | 2 | +357.8% |
| ☆ZNTL funds › | ZENTALIS PHARMACEUTICALS INC | ADD | — | 6.1% | +2.7% | 17.9 | 3,700,000 | +69,000 | 2 | +100.9% |
| ☆EWTX funds › | EDGEWISE THERAPEUTICS INC | TRIM | Common Stock | 4.0% | -0.4% | 11.8 | 290,000 | -60,000 | 2 | — |
| ☆MAZE funds › | MAZE THERAPEUTICS INC | ADD | Common Stock | 3.4% | +0.3% | 10.0 | 335,000 | +77,500 | 2 | — |
| ☆IVA funds › | INVENTIVA SA | ADD | ADR | 3.2% | +2.0% | 9.2 | 2,435,000 | +1,900,000 | 2 | — |
| ☆ANL funds › | ADLAI NORTYE LTD | TRIM | ADR | 3.0% | -0.5% | 8.8 | 764,876 | -500,355 | 2 | +61.3% |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | NEW | Common Stock | 2.8% | +2.8% | 8.1 | 160,000 | +160,000 | 1 | +390.8% |
| ☆PALI funds › | PALISADE BIO INC | HOLD | — | 2.1% | +0.0% | 6.3 | 3,000,000 | +0 | 2 | — |
| ☆IKT funds › | INHIBIKASE THERAPEUTICS INC | TRIM | Common Stock | 2.1% | -0.3% | 6.1 | 3,000,000 | -500,000 | 2 | — |
| ☆ADAG funds › | ADAGENE INC | NEW | ADR | 1.8% | +1.8% | 5.2 | 1,250,000 | +1,250,000 | 1 | +19.5% |
| ☆FBRX funds › | FORTE BIOSCIENCES INC | NEW | — | 1.6% | +1.6% | 4.8 | 225,000 | +225,000 | 1 | — |
| ☆IFRX funds › | INFLARX NV | NEW | — | 1.5% | +1.5% | 4.5 | 2,000,000 | +2,000,000 | 1 | -81.3% |
| ☆ASMB funds › | ASSEMBLY BIOSCIENCES INC | NEW | Common Stock | 1.5% | +1.5% | 4.4 | 160,000 | +160,000 | 1 | +90.1% |
| ☆PMN funds › | PROMIS NEUROSCIENCES INC | HOLD | — | 1.5% | -0.2% | 4.3 | 324,977 | +0 | 2 | -47.5% |
| ☆CTNM funds › | CONTINEUM THERAPEUTICS INC | NEW | Common Stock | 1.5% | +1.5% | 4.3 | 260,000 | +260,000 | 1 | +26.2% |
| ☆CMPS funds › | COMPASS PATHWAYS PLC | NEW | ADR | 1.5% | +1.5% | 4.2 | 300,000 | +300,000 | 1 | +148.7% |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | NEW | Common Stock | 1.4% | +1.4% | 4.0 | 85,000 | +85,000 | 1 | +1972.2% |
| ☆SLGL funds › | SOL-GEL TECHNOLOGIES LTD | ADD | — | 1.3% | +0.3% | 3.9 | 52,000 | +21,000 | 2 | +1.1% |
| ☆BIOA funds › | BIOAGE LABS INC | NEW | Common Stock | 1.3% | +1.3% | 3.8 | 155,000 | +155,000 | 1 | -102.7% |
| ☆SCYX funds › | SCYNEXIS INC | NEW | — | 1.1% | +1.1% | 3.1 | 756,884 | +756,884 | 1 | -45.1% |
| ☆PRQR funds › | PROQR THRAPEUTICS N V | NEW | — | 1.0% | +1.0% | 2.8 | 1,511,496 | +1,511,496 | 1 | +146.8% |
| ☆RZLT funds › | REZOLUTE INC | NEW | — | 0.7% | +0.7% | 2.1 | 403,410 | +403,410 | 1 | +304.1% |
| ☆CUSIP:53630X203 funds › | LIPOCINE INC NEW | ADD | — | 0.7% | -0.7% | 2.1 | 810,000 | +360,000 | 2 | — |
| ☆CUE funds › | CUE BIOPHARMA INC | NEW | Common Stock | 0.5% | +0.5% | 1.6 | 50,000 | +50,000 | 1 | +578.5% |
| ☆CALC funds › | CALCIMEDICA INC | NEW | — | 0.4% | +0.4% | 1.3 | 1,244,864 | +1,244,864 | 1 | +18.0% |
| ☆QNCX funds › | QUINCE THERAPEUTICS INC | NEW | Common Stock | 0.3% | +0.3% | 0.7 | 40,375 | +40,375 | 1 | +804.0% |
| ☆KTTA funds › | PASITHEA THERAPEUTICS CORP | TRIM | — | 0.2% | -0.4% | 0.5 | 1,000,000 | -1,100,000 | 2 | — |
| ☆INM funds › | INMED PHARMACEUTICALS INC | NEW | Common Stock | 0.2% | +0.2% | 0.5 | 325,000 | +325,000 | 1 | +2313.5% |
| ☆NMRA funds › | NEUMORA THERAPEUTICS INC. | NEW | — | 0.1% | +0.1% | 0.2 | 100,000 | +100,000 | 1 | -58.5% |
| ☆NXTC funds › | NEXTCURE INC | TRIM | — | 0.0% | -1.1% | 0.1 | 64,464 | -200,536 | 2 | — |
| ☆NKTR funds › | NEKTAR THERAPEUTICS | EXIT | — | 0.0% | -3.6% | 0.0 | 0 | -125,000 | 0 | -65.6% |
| ☆HOWL funds › | WEREWOLF THERAPEUTICS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -563,535 | 0 | -107.8% |
| ☆TRAW funds › | TRAWS PHARMA INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -511,714 | 0 | — |
| ☆CNTX funds › | CONTEXT THERAPEUTICS INC | EXIT | Common Stock | 0.0% | -1.2% | 0.0 | 0 | -1,100,000 | 0 | -66.9% |
| ☆CUSIP:811292200 funds › | SCYNEXIS INC | EXIT | — | 0.0% | -2.8% | 0.0 | 0 | -7,608,695 | 0 | — |
| ☆EPRX funds › | EUPRAXIA PHARMACEUTICALS INC | EXIT | Common Stock | 0.0% | -2.0% | 0.0 | 0 | -680,000 | 0 | — |
| ☆ALXO funds › | ALX ONCOLOGY HLDGS INC | EXIT | Common Stock | 0.0% | -1.2% | 0.0 | 0 | -1,460,000 | 0 | -79.3% |
| ☆GHRS funds › | GH RESEARCH PLC | EXIT | — | 0.0% | -1.8% | 0.0 | 0 | -325,000 | 0 | — |
| ☆ABVX funds › | ABIVAX SA | EXIT | ADR | 0.0% | -5.8% | 0.0 | 0 | -130,000 | 0 | — |
| ☆CUSIP:483497103 funds › | KALVISTA PHARMACEUTICALS INC | EXIT | — | 0.0% | -7.9% | 0.0 | 0 | -985,100 | 0 | — |
| ☆SPRB funds › | SPRUCE BIOSCIENCES INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -12,200 | 0 | — |
| ☆CUSIP:88338N206 funds › | THERAPEUTICSMD INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -420,421 | 0 | — |
| ☆NEUP funds › | NEUPHORIA THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -76,728 | 0 | +45.2% |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 292 | 34 | 0.38 | 73% | 0.078 | 0.135 | — | in |
| 2026Q1 | 250 | 30 | 0.40 | 73% | 0.095 | 0.123 | — | entered |
| 2025Q4 | 224 | 29 | 0.00 | 69% | 0.068 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status